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The health plan benefits-selection process requires
consumers to understand myriad health plan jargon,
processes, and rules to select appropriate, affordable
coverage that adequately meets their health care
needs. Thus, adequate consumer knowledge about
health plan coverage facilitates the appropriate se-
lection of health benefit coverage in a market-based
system. Market choice of health insurance coverage
is premised on the idea that consumers have adequate
knowledge to rationally discern among the many nu-
ances of health plan coverage.1
Adequate knowledge about health plan coverage
has also been recognized as an integral component of
health plan quality-assurance programs. The Con-
sumer Assessment of Health Plans (CAHPS) asks sur-
vey respondents a series of questions to ascertain con-
sumer understanding of written health plan materials
and paperwork.2 The National Committee for Qual-
ity Assurance, Washington, DC, in turn, uses 
CAHPS as part of its health plan accreditation process.
Additionally, the Medicare Current Beneficiary 
Survey (MCBS) uses both a perceived knowledge in-
dex and a quiz to assess Medicare beneficiaries’ pro-
gram knowledge in its monitoring and evaluation ac-
tivities.3
Prescription drug benefits add to the complexity of
health plan benefits selection. In managed pharmacy
benefits, administrators typically employ a variety of
unique and ever-evolving cost-containment strate-
gies,4,5 further underscoring the need for more educated
consumers. An employee with inadequate knowledge
of cost sharing who makes a suboptimal benefit selec-
tion based on lowest premium cost may experience
downstream consequences of higher cost sharing and
restricted formularies, which may subsequently influ-
ence adherence to prescribed treatment regimens. 
A report to the Department of Health and Human
Services questioned whether consumers were
“equipped to make good choices regarding their
health and drug use. . .”5 The report concluded, in part,
that improving consumer decision making through in-
formation about drug “need, appropriateness, and
cost” could help manage runaway drug expenditures.5
Previous studies have similarly demonstrated that
nonelderly consumers have limited understanding of
the issues that are fundamental to their choice of
health plan coverage, including provider board 
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certification, staff privileges, and licensure.6 They are
more knowledgeable about hospital coverage than
outpatient physician and drug services7; they have
limited understanding of methods used to manage
care8; and they typically underreport coverage for out-
patient medical care, mental health and substance
abuse services, and prescription drugs.9 These stud-
ies have called for better patient understanding of
health plan coverage in response to free market com-
petition for enrollees in the private sector.
Despite the increasing prominence of prescription
drugs and consistent growth in pharmaceutical ex-
penditures,10 little attention has been devoted to 
exploring how employees understand the mechanics
of pharmacy benefits. A recent study evaluating the
effect of a three-tier prescription copay on medical care
utilization acknowledged the lack of research in pa-
tient understanding of tiered pharmaceutical benefits.11
Another study used personal interviews to measure
consumer knowledge of various topics related to phar-
macy benefits including “generic versus brand name is-
sues,” “medication formularies,” “pharmacy networks,”
and “cost-sharing arrangements.”12 Although a major-
ity of patients could differentiate between generic and
brand name drugs, only a minority were able to grasp
the concept of a medication formulary. Beyond the bat-
tery of questions used in this study, additional published
empirical research that has objectively addressed con-
sumers’ knowledge of pharmacy benefits is limited. A
recently reported study of consumer knowledge of for-
mularies employed attitudinal, rather than objective,
measures to assess pharmacy benefits knowledge.13 A
minority of the respondents reported having a copy of
the formulary, being aware of the information covered
in it, and were motivated to seek more information re-
garding formularies. For both studies, however, inabil-
ity to verify respondents’ actual pharmacy benefits lim-
ited the interpretation of response accuracy. 
The introduction of multitier benefit designs in-
creases the complexity of pharmacy benefits are be-
coming increasingly complex.14 Under ideal circum-
stances, insurers and employers should provide
educational information about the benefit offerings to
their constituents, assess understanding of the infor-
mation provided, and target educational interventions
where knowledge deficits are identified. Although
some employers and insurers do provide compre-
hensive educational materials about pharmacy ben-
efits, little is known about how well their constituents
understand and translate this information into knowl-
edge. The purpose of this article is to explore em-
ployee knowledge of pharmacy benefits and identi-
fy factors associated with varying levels of knowledge.
S U B J E C T S  A N D  M E T H O D S
A self-administered questionnaire was distributed in
March 2002 through interoffice mail to each of 1,380
active, full-time employees (age, ≥ 18 yr), of a large
university in western Pennsylvania. Employees re-
ceived the questionnaire nine months after the be-
ginning of the coverage year, and one month before
the beginning of open enrollment for the subsequent
year (to capture maximum employee experience
with current benefit information and avoid confusion
with benefit information for the subsequent benefit
yr). All employees were surveyed to ensure repre-
sentation of a range of demographic and occupational
classifications. For the health plan coverage year from
July 2001 until June 2002, employees had received the
same summary of health plan and pharmacy benefits
information that described the choices of a core ben-
efit (i.e., a comprehensive major medical plan simi-
lar to traditional indemnity insurance), two PPOs, and
three HMOs. Each employee also had the option of
waiving health plan benefits.
During the open enrollment period for that benefit
year, all employees had been given a booklet sum-
marizing health and prescription drug benefits. The
pharmacy benefit associated with the core benefit used
a coinsurance and deductible without restriction. Al-
ternatively, the pharmacy benefits associated with the
PPOs and HMOs employed a formulary with a three-
tier copay emphasizing generic substitution and a de-
fined pharmacy network, and it offered a mail-order
pharmacy option. For the PPOs and HMOs, the phar-
macy benefit manager depended on the type of health
plan selected. However, the contract language of the
prescription drug benefits was identical regardless of
who managed the benefit. 
This study focused on employees who enrolled in
a PPO or HMO with a managed pharmacy benefit. The
first section of the questionnaire identified them. The
second section solicited information about the type of
pharmacy benefit information respondents received,
where and from whom they obtained this, to what ex-
tent they read this information, and asked for a self-
reported estimate of their understanding of pharma-
cy benefits. It was believed that these combined factors
have the potential to influence the degree of knowl-
edge of pharmacy benefits.
The third section of the questionnaire tested em-
ployee understanding of commonly used terminolo-
gy appearing in educational information for pharmacy 
benefits. A review of prominent regional health
plans’ benefits explanations, educational information
provided to employees, and advertising materials re-
vealed common, recurring insurance industry-specific
jargon and processes that may be confusing to an em-
ployee. Questions representing four content areas of
pharmacy benefits were derived from the benefits ma-
terials distributed to employees during open enroll-
ment: (1) generic versus brand name issues, (2)
provider network arrangements, (3) formulary con-
siderations, and (4) cost-sharing arrangements.  
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Initially, a 16-item true–false knowledge test was 
developed. Pharmacy academicians and researchers 
reviewed the initial draft of the true–false questions
to evaluate their rationale, content validity, practical-
ity, and functionality. Revisions were made based on
feedback obtained. The revised instrument was then
administered to five subjects who varied in age, race,
and gender. These respondents understood the ques-
tionnaire and completed it without significant prob-
lems. Minor revisions were made based on feedback
obtained. In response to concern from content re-
viewers that the true–false  format may lead to guess-
ing and subsequently overestimate respondent knowl-
edge, a 14-item multiple-choice knowledge test was also
developed. The increased complexity of the multiple-
choice questionnaire allowed for simulation of more 
integrated decision making requiring the respondent to
assess multiple related concepts at one time.  
Each version of the knowledge test represented the
four content areas of interest. Regardless of the ver-
sion, every knowledge item provided a “don’t
know/not sure” response option. Multiple questions
were asked about each content area to explore a broad-
er understanding of each concept. Questions on the
true–false questionnaire were presented in a scram-
bled order of topics with varied correct response choic-
es to avoid a pattern of responses within each content
area. Owing to the complexity inherent in its format,
the multiple-choice questionnaire posed queries in a
manner generally ordered by content area. 
Each question was scored as correct or incorrect by
comparing employee responses with the pharmacy
benefit information provided to all full-time em-
ployees. The “don’t know/not sure” responses were
considered incorrect for scoring purposes, a technique
that has been used in previous research.6 A knowledge
index, representing each respondent’s total score, was
constructed by summing the correct answers.15
An additional section of each questionnaire collect-
ed self-reported information on the recency and fre-
quency of filling a prescription, because a direct rela-
tionship between use and knowledge of pharmacy
benefits could exist. The final section of each ques-
tionnaire contained questions eliciting demographic in-
formation to describe the respondent sample, includ-
ing age, sex, education level, family income, and
self-reported health status. The questionnaire did not
contain any personal identifying information, thus as-
suring the anonymity of responses. The Institutional
Review Boards of Duquesne University (Pittsburgh)
and the University of Pittsburgh approved the study.
The Human Resource (HR) Benefits Department  at
the subject university identified, selected, and creat-
ed one set of interoffice mailing labels for all full-time
employees. Labeled distribution envelopes contained
a cover letter, a questionnaire, and a self-addressed
return envelope. Every other employee received the
multiple-choice questionnaire to achieve similar dis-
tributions of both versions. 
One week before distribution of the questionnaire,
a representative from HR sent an E-mail to employees
alerting them to the distribution of the questionnaire.
Using a return envelope provided, questionnaires were
returned to a specified address through interoffice mail.
One week after distribution, a representative from HR
sent a follow-up E-mail to all employees encouraging
completion of the questionnaire.
Raw data were entered into a database by the
principal investigator. After entering data from each
respondent, the principal investigator reviewed the
entries as a quality assurance check to ensure accu-
racy. The final coding of difficult-to-interpret survey
responses, such as selection of more than one re-
sponse choice or the mark of a response choice out-
side the designated response field, was adjudicat-
ed by both investigators. Data were exported to Stata
7 (Stata Statistical Software, College Station, TX) for
analysis. An a priori significance level of .05 was es-
tablished for all statistical testing.
Descriptive statistics were used to profile the re-
spondent sample for each questionnaire, responses for
each knowledge item, and overall test score. The 
Kuder–Richardson Formula 20 (KR-20) was used to
assess internal consistency for each knowledge index
measure. Individual relationships between demo-
graphic and background variables and knowledge of
pharmacy benefits were explored using bivariate
analyses. Using a stepwise, backward elimination
strategy with a probability of variable removal set to
0.10, multivariate regression was used to explore the
relationship between the collective set of demographic
and background variables and knowledge of phar-
macy benefits. The post hoc analyses were performed
using a Bonferroni adjustment. 
A gold standard does not exist to which the knowl-
edge of pharmacy benefits measures revealed in this
study can be compared. Therefore, the method of
known groups validity was employed to determine
whether variables expected to differ with respect to
health plan knowledge would also differ with respect
to knowledge of pharmacy benefits. This technique
has been reported and used in previous research of
health plan benefit knowledge.6–8
R E S U LT S  
Questionnaires were collated by department and lo-
cation from the employee mailing list and distributed
to all 1,380 full-time employees. The number of ques-
tionnaires distributed for the true–false (686) and 
multiple-choice (694) versions differed slightly owing
to odd numbers of employees within some depart-
ments. A total of 536 completed questionnaires were
returned (269 true–false, 267 multiple choice) for an
unadjusted response rate of 38.8%. This research 
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focused on employer-sponsored managed pharmacy
benefits; respondents not reporting health care cov-
erage or reporting other health care coverage (N = 67)
were excluded from analyses since their responses to
the knowledge questions could not be objectively ver-
ified. Respondents reporting only a core health in-
surance benefit (N = 14) were also excluded, because
they did not have a managed pharmacy benefit and
their orientation to the knowledge questions may dif-
fer from those respondents with a managed pharma-
cy benefit. The small sample size of the core benefit
group would also make it difficult to draw meaning-
ful conclusions from any comparative analysis. The
employer documented that 300 employees waived
health plan and pharmacy benefits during the study
year, reducing the target population to 1,080 em-
ployees. Using the revised target population and con-
sidering the excluded responses, the adjusted response
rate was 41.7% (455/1,080).       
Age, sex, race, ethnic origin, education level,
household income, and self-reported health status
characteristics are reported in Table I. In general, the
study sample was predominantly Caucasian, female,
well educated, and in self-reported good to very good
health. The observed distribution of respondent de-
mographic characteristics receiving the true–false and
multiple-choice questionnaires were similar, as veri-
fied by nonsignificant bivariate analyses. Of the 455
respondents, 72.3% selected an HMO, and 27.7% se-
lected a PPO. Bivariate analyses revealed no rela-
tionship between health plan type and age, minority
status, education, or income.
Although all employees were given written ex-
planations of pharmacy benefits, only two-thirds of
respondents acknowledged receiving written infor-
mation about prescription drug coverage and one-
third acknowledged receipt of information in a ver-
bal format (Table II). With the exception of number of
prescriptions filled within the past 30 days, respon-
dent background characteristics did not differ sig-
nificantly by questionnaire type.
Interestingly, 26.3% of respondents reported re-
ceiving both written and verbal information about their
health plan, 17.6% reported not receiving any type of
information, and 2.3% did not know or were not sure
they had received any type of information. The majority
of respondents reported fair to good understanding of
their pharmacy benefits, and three-fourths reported
having a prescription filled during the previous 30
days. Of the 333 respondents who reported having a
prescription filled within 30 days of completing the
questionnaire, 69.7% indicated they had received
written information within the previous year compared
with only 57.29% of the 96 respondents who did not
have a prescription filled within 30 days of complet-
ing the questionnaire (χ2 = 5.16, P = .023). The rela-
tionship between having a prescription filled within the
past 30 days and having received verbal information
was not significant (χ2 = 0.79, P = .374). Of the 115 re-
spondents who indicated they did not receive or did
not know they received information about prescription
drug coverage, approximately two thirds (67.8%) had
a prescription filled within 30 days of completing the
questionnaire, compared with 81.0% of the 311 re-
spondents who reported receiving any type of infor-
mation (χ2 = 8.38, P = .004).
The proportions of respondents who correctly an-
swered each of the true–false and multiple-choice
knowledge questions are provided in Tables III and
IV, respectively. In general, the proportion of correct
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TABLE I: SAMPLE DEMOGRAPHIC 
CHARACTERISTICS BY TYPE OF 
KNOWLEDGE TESTS*
TF MC
Demographic Variable (N = 234)† (N = 221)‡
Age (yr)
20–29  8.12% 6.33%
30–39 17.09% 15.84%
40–49 27.35% 34.39%
50–59  32.48% 33.03%
≥ 60 10.26% 9.50%
unknown 4.70% 0.90%
Gender
male 32.91% 39.37%
female  66.67% 60.18%
unknown 0.43% 0.45%
Race/Ethnicity
Caucasian non-Hispanic 91.45% 91.40%
non-Caucasian/Hispanic 6.41% 7.24%
unknown 2.14% 1.36%  
Highest Educational Attainment
high school (9–12 yr) 18.80% 19.46%
trade school 9.83% 4.98%
associates degree 11.54% 7.24%
bachelors degree 16.67% 16.29%
graduate or professional degree 41.88% 50.68%
unknown 1.28% 1.36 %
Yearly Household Income
≤ $25,000 7.69% 5.88%
$25,001–$50,000 27.78% 25.34%
$50,001–$75,000  25.21% 27.60%
$75,001–$100,000  13.68% 17.19%
> $100,000  17.52% 17.65% 
unknown  8.12% 6.33%  
Perceived Health Status
poor  0.43% 0.45%
fair  4.70% 4.98%
good  40.60% 34.39%
very good  38.03% 42.08%
excellent  15.38% 17.65%
unknown  0.85% 0.45%
*Proportion of total responses for each demographic variable.
†Total number of responses for true–false questionnaire.
‡Total number of responses for multiple-choice questionnaire.
TF = True–false test; MC = multiple-choice test; N = number.
responses was higher on the true–false questionnaire
than on the multiple-choice test. The proportions of
respondents correctly answering questions about for-
mulary considerations were consistently lower com-
pared with other content areas on both true–false and
multiple-choice questionnaires.  The highest propor-
tions of “don’t know” responses were also associat-
ed with questions related to formulary considerations. 
For respondents completing all knowledge ques-
tions, correct responses were summed into a knowl-
edge index score. For both knowledge indexes, the
scores were normally distributed. The mean knowl-
edge index score was 9.9 ± 2.6 (standard deviation)
for the 16-item true–false questionnaire, equating to
a sample average of 62% correct. For the 14-item 
multiple-choice questionnaire, the mean knowledge
index score was 7.4 ± 2.5, an average of 53% correct.
Each knowledge index had similar proportions of
“don’t know” responses—27% for the true–false
questionnaire and 26.2% for the multiple-choice
questionnaire. Both instruments appear to discern
among low and high levels of knowledge, as evi-
denced by the wide distribution of scores for the
true–false (3–16) and multiple-choice (0–13) ques-
tionnaires.
With respect to the questionnaire reliability and
construct validity, internal consistencies for the 
16-item true–false measure (alpha = .65) and 14-item
multiple-choice measure (alpha = .63) were compa-
rable and consistent with previous published litera-
ture on health plan knowledge.6 Bivariate analyses 
revealed, a significant positive relationship between
perceived level of understanding of pharmacy bene-
fits and knowledge score on both the true–false (P =
.0095) and multiple choice (P = .0001) measures. 
Respondents to the true–false measure who per-
ceived their pharmacy benefit knowledge to be ex-
cellent had significantly higher pharmacy benefit
knowledge scores than respondents who perceived
their pharmacy benefit knowledge to be poor (P =
.007). Respondents to the multiple-choice measure
who perceived their pharmacy benefit knowledge to
be excellent, good, or fair had significantly higher
knowledge scores than respondents who perceived
their pharmacy benefit knowledge to be poor (P =
.0001, P = .0001, P = .031, respectively). Respondents
who perceived their pharmacy benefit knowledge to
be excellent or good also had significantly higher
pharmacy benefit knowledge scores than those who
perceived their knowledge to be fair (P = .003, P = .009,
respectively). Questionnaire respondents who ac-
knowledged receipt of written pharmacy benefit 
explanations scored significantly higher than those who
did not acknowledge receipt of benefits explanations
on both the true–false (P = .0013) and multiple-choice
(P = .0133) measures. For bivariate analyses, the 
income variable was collapsed to greater or less than
$50,000. Respondents whose annual family income ex-
ceeded $50,000 scored higher on both the true–false
(P = .0438) and multiple-choice (P = .0229) knowledge
of pharmacy benefit measures. Compared with non-
Caucasian/Caucasian-Hispanic respondents, Cau-
casian non-Hispanic respondents demonstrated sig-
nificantly higher knowledge of pharmacy benefit
scores on the true–false questionnaire (P = .0079). Hav-
ing a prescription filled within the previous 30 days
was positively related to knowledge of pharmacy ben-
efit score on the true–false measure (P = .0316). Al-
though education level was related to health plan ben-
efits knowledge in previous research,6,8 it was not
significantly related to knowledge of pharmacy ben-
efit in this study. This finding may be attributable to
the homogeneity of the respondent sample, but it
could also be the result of knowledge of pharmacy
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TABLE II: PRESCRIPTION BENEFIT
COVERAGE, INFORMATION RECEIVED AND
PERCEIVED UNDERSTANDING, AND 
PRESCRIPTION UTILIZATION PATTERNS BY
TYPE OF KNOWLEDGE TEST*
TF MC
Descriptive Variable (N = 234)† (N = 221)‡
Current Health Care Coverage for Prescription Drugs
yes 97.86% 96.38%
no/don’t know  1.70% 2.71%
unknown 0.43% 0.90%
Received Written Information Describing 
Prescription Drug Coverage     
yes 65.81% 63.80%
no/don’t know 32.05% 32.13% 
unknown 2.14% 4.07%  
Received Verbal Information Describing Prescription Drug 
Coverage     
yes 31.20% 30.32%
no/don’t know 66.67% 64.71%
unknown 2.14% 4.98%
Perceived Understanding of Prescription Drug Coverage 
poor 9.40% 8.14%
fair 34.19% 39.82%
good 42.74% 38.01%
excellent  8.55% 8.14%
unknown 5.13% 5.88%
Had Prescription Filled During the Past 30 Days     
yes 75.64% 74.21%
no 21.37% 23.53%
unknown  2.99% 2.26%
Prescriptions Filled During the Past 30 Days (N)     
none 20.94% 24.43%
1–2   41.88% 40.27%
3–4   18.80% 25.79% 
≥ 5   15.38% 7.24% 
unknown  2.99% 2.26%  
*Proportion of total responses for each demographic variable.
Total number of responses for “true-false” questionnaire.
‡Total number of responses for “multiple-choice” questionnaire.
TF = True/false test; MC = multiple-choice test; N = number.
benefit being a unique construct. Age, sex, receipt of
verbal information describing prescription drug cov-
erage, perceived health status, number of prescrip-
tions filled within 30 days, and health plan type were
also not related to knowledge of pharmacy benefit.
Multivariate regression analysis indicated that
some variables were significantly related to pharma-
cy benefit knowledge scores. Acknowledged receipt
of written pharmacy benefit information (P = .017),
perceived excellent understanding of pharmacy ben-
efit (P = .039), and having a graduate or professional
degree (P = .006) were positively related to pharmacy
benefit knowledge for true–false questionnaire re-
spondents. For multiple-choice questionnaire respon-
dents, self-reported income greater than $50,000 (P =
.006) and perceived fair (P = .003), good (P = .001), and
excellent (P = .001) understanding of pharmacy ben-
efit were positively related to knowledge of pharma-
cy benefit scores. Final multivariate models for each
pharmacy benefit knowledge measure had limited
predictive power. The final model for the true–false
measure had less explanatory power (adjusted R2 =
.11) compared with the model for the multiple-choice
measure (adjusted R2 = .22).
D I S C U S S I O N
Using two alternative testing methods, this research
contributes an initial view into a variety of aspects of
employees’ understanding of managed pharmacy
benefits in a large employer sample.
Although acknowledged receipt of written benefits
information was positively related to higher knowl-
edge of pharmacy benefits, only two-thirds of re-
spondents actually acknowledged receipt of written
pharmacy benefit explanations. Although written
pharmacy benefit explanations are provided to all 
employees in this employer group, the large minority
of respondents failing to acknowledge receipt raises
concern about their awareness that pharmacy bene-
fit information is an integral component of their health
care benefits package. As the complexity of benefits
continues to increase, passive dissemination of in-
formation may no longer suffice. Decision-making
tools that require active employee participation in de-
termining their pharmacy benefit needs within the
context of their overall health care needs and finan-
cial capacity should be developed and used to enhance
employee awareness of their pharmacy benefits.17
Is pharmacy benefit knowledge only important
when the benefit is being used? If this were true, one
may expect verbal information about pharmacy ben-
efits to be associated with recent prescription uti-
lization and higher pharmacy benefit knowledge since
verbal discussions are most likely to occur at the point
of service, whereas written information is most like-
ly to be distributed at the beginning of the enrollment
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TABLE III: PERCENTAGE OF CORRECT RESPONSES FOR 16 
TRUE–FALSE KNOWLEDGE QUESTIONS
N* Correct Don’t Know
Generic/Brand Name Issues
1. Generic drugs are less effective than brand name (F) 227 83.70% 9.69%
2. Requesting brand name in lieu of generic causes you to pay a higher amount (T) 230 92.17% 5.22%
3.  Amount employee pays for brand name is less than for generic (F) 229 88.21% 4.37%
4. Using generic drugs helps to minimize insurance premium increases (T) 229 65.50% 29.26%  
Provider Network Arrangements      
5. Pharmacies accepting your insurance belong to a network (T) 229 80.35% 13.10%  
6. Prescriptions filled out of network require higher payment (T) 228 74.12% 19.74%  
7. Obtaining medications for chronic conditions through mail order will reduce 
out-of-pocket costs (T) 229 69.43% 27.07%  
8. Network pharmacies accept your insurance card (T) 229 84.72% 10.04%
Formulary Considerations    
9. Health insurers use a preferred drug list to maximize quality/value (T) 230 44.78% 43.91%  
10. A preferred drug list is known as a formulary (T) 227 31.72% 64.76%  
11. Amount employee pays may be higher if not on the preferred drug list(T) 230 53.04% 41.74%  
12. Employer has input into the development of the preferred drug list (T) 228 10.96% 60.09%  
13. Physicians/pharmacists do not have input into the preferred drug list (F) 230 23.48% 59.57%
Cost-Sharing Arrangements
14. Out-of-pocket cost for Rx drug is known as a copay (T) 230 97.39% 0.43%  
15. Another name for copay is coinsurance or deductible (F) 228 25.44% 21.05%  
16. Employees pay the largest portion of cost for prescription drugs (F) 229 65.07% 22.27%  
*Total number (N) of valid responses for each knowledge question, excluding unknown data.
†Proportion of “don’t know” responses for each knowledge question.
T = True; F = false; Rx = prescription.
period. This research questions the aforementioned
assumption, since only written information explain-
ing pharmacy benefits was significantly associated
with recent prescription use and higher pharmacy
benefit knowledge scores.
Concern over the possibility of successful guessing
and artificially inflated knowledge scores from using
only a dichotomous response set (true–false) led the
researchers to employ an alternative multiple-choice
format. Compared with the multiple-choice items, the
consistently higher proportions of respondents with
correct answers for the true–false items, similar pro-
portions of respondents with “don’t know” respons-
es, and the homogeneous respondent samples for both
questionnaires strengthened these suspicions. Previ-
ous health plan benefit–knowledge research that has
been limited to dichotomous choice (e.g., agree/
disagree, yes/no) responses6,8 may have overesti-
mated levels of knowledge. Future research that is
conducted on health plan and knowledge of pharmacy
benefits should incorporate more comprehensive
and diverse item construction, using both types of
question formats, to further evaluate this phenomenon.
This was the first study to objectively verify and
describe the state of knowledge of pharmacy benefits
in a large employer population. Regardless of the
questionnaire used, employees demonstrated low to
moderate overall knowledge of pharmacy benefits.
Considering this limited knowledge, further exami-
nation of the implications of specific areas of knowl-
edge deficit is warranted.
Given that the use of generic drugs has grown sig-
nificantly in the recent past, respondents indicated sub-
stantial understanding of the clinical equivalence be-
tween generic and brand name drugs and appeared to
recognize that the use of generic drugs leads to lower
out-of-pocket costs. Fewer respondents, however,
could identify how and why generic drugs reach the
market, why they cost less, and their important role in
minimizing insurance premium increases. Improving
the understanding of these concepts may further reas-
sure consumers that generic drugs are safe, effective,
and play an important role in health care cost contain-
ment. This reassurance and improved understanding
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TABLE IV: PERCENTAGE OF CORRECT RESPONSES FOR 
14 MULTIPLE-CHOICE KNOWLEDGE QUESTIONS
N* Correct Don’t Know†
Generic/Brand Name Issues
1. Generic drugs have the same active ingredient and strength as their brand 209 89.95% 3.83% 
name alternatives 
2. Generic drugs are not available until the original brand name comes off patent and 206 48.06% 18.93% 
cost less due to fewer research and advertising costs
3. I pay one price for generics, a higher price for brand name drugs on the preferred list, 209 23.92% 13.40%
and an even higher price for brand name drugs not on the preferred list 
Provider Network Arrangements      
4. In order for my prescription to be covered by my plan I must have it filled at a network 210 89.05% 7.14%
pharmacy 
5. If I do not fill my prescription at a pharmacy specified by my prescription drug plan, 210 38.10% 39.52%
I have to pay the full price for the prescription 
6. Mail-order pharmacies are best used to obtain medications for chronic conditions 208 48.08% 47.12%
Formulary Considerations
7. A health insurance company often refers to a list of preferred drugs as a formulary 212 24.06% 53.77%  
8. The list of preferred drugs is developed by my employer and health professionals 210 28.10% 50.95%
hired by my insurance company
9. The list of preferred drugs is developed and maintained to ensure standard benefits, 207 44.44% 19.81%
control costs and minimize premium increases, and ensure quality drug use
10. For medications covered by my prescription drug insurance, the preferred drug is 210 57.14% 16.19%
typically a generic drug unless a generic is not available to treat the condition 
Cost-Sharing Arrangements
11. The amount that I have to pay for each prescription I obtain using my insurance is 212 92.45% 4.72%
called a copayment 
12. The amount that I have to pay when I obtain a prescription covered by my health plan 212 85.85% 9.43%
is determined by my employer and my health insurance company 
13. My employer pays the largest portion of the cost for most prescription drugs obtained 211 23.22% 25.12%
through my prescription drug plan 
14. I have no limit on the number of prescriptions I can obtain with my plan 210 47.14% 48.57%  
*Total number (N) of valid responses for each knowledge question, excluding unknown data.
†Proportion of “don’t know” responses for each knowledge question.
may further enhance generic drug uti-
lization.
Large proportions of respondents
failed to understand the financial conse-
quences of using an out-of-network phar-
macy provider and of not adhering to the
precepts of tiered pharmacy benefits.
Since this research identified household
income to be positively related to over-
all knowledge of pharmacy benefits, a
lack of awareness of these financial con-
sequences may place the greatest fiscal
strain on those who can least afford it. In-
creasingly smaller provider networks
may exacerbate these burdens.18 For 
example, a patient may have to incur ad-
ditional travel expenses to access a net-
work provider. This is especially trou-
blesome for those without easy access to
travel and/or a well-established social
support network. Although an employ-
ee may quickly learn that there is a fi-
nancial penalty for using a nonnetwork
provider, selecting a pharmacy benefit
that excludes a convenient provider with
whom they have a positive rapport
forces them to make difficult choices be-
tween cost and provider. Once enrolled,
benefits are typically in place for one
year. Thus, a suboptimal benefit choice
may decrease convenience, require an 
undesired change in provider related to
financial reasons, and ultimately lead to 
beneficiary dissatisfaction. Potential dis-
satisfaction should concern pharmacy
benefit managers and should under-
score the importance of a fully informed
consumer.  
Only a minority of respondents was
able to correctly identify that mail-order
pharmacies are best used for obtaining
chronic medications; a majority under-
stood that the use of mail-order phar-
macies for obtaining chronic medications
reduces out-of-pocket costs. Efforts made
to increase the utilization of mail-order
pharmacy services stand the greatest
chance for success if consumers under-
stand the conditions under which such
programs should be used, along with the
financial benefits of their use.
Consistent with previously published
research,12 only a minority of respon-
dents understood the terminology used
to describe medication formularies, the
purpose of medication formularies, and
who has input into their development.
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TABLE V: MEAN KNOWLEDGE SCORE FOR SELECT
CHARACTERISTICS BY KNOWLEDGE TEST
TF Score* MC Score†
(maximum = 16) (maximum = 14)
Variable/Response Category Mean P Mean P
Age (yr) 
20–29 9.83 .1314‡ 6.31 .1494‡
30–39 9.72 7.59
40–49 9.83 7.31
50–59 10.50 7.35
≥ 60 8.87 8.61
Gender
male 9.75 .5226§ 7.46 .8411§
female 9.99 7.39
Race/Ethnicity
Caucasian non-Hispanic 10.07 .0079§ 7.49 .0835§
non-Caucasian/Hispanic 8.14 6.23
Highest Educational Attainment
high school (9–12 yr) 9.93 .0556‡ 7.14 .6364‡
trade school or associate degree 9.45 7.00 
bachelors degree 9.29 7.44
graduate or professional degree 10.47 7.62
Yearly Household Income
≤ $50,000  9.43 .0438§ 6.78 .0229§  
> $50,000  10.20  7.70   
Perceived Health Status
poor to good  9.55 .0638§ 7.54 .5904§
very good to excellent  10.23  7.34   
Received Written Information Describing Prescription Drug Coverage
yes  10.32 .0013§ 7.75 .0133§ 
no/don’t know  9.10  6.81   
Received Verbal Information Describing Prescription Drug Coverage
yes 10.07 .6269§ 7.41 .9440§
no/don’t know  9.89  7.44   
Perceived Understanding of Prescription Drug Coverage 
poor   8.77¶ .0095‡ 5.06 .00001‡ 
fair  9.73  6.88,**
good   10.08  8.09,**
excellent 11.47¶  9.29,**   
Had Prescription Filled During the Past 30 Days 
yes  10.14 .0316§ 7.55 .1437§ 
no  9.17  6.91
Health Plan Type
A (PPO)  10.09 .6823‡ 7.74 .5640‡
B (PPO)  10.38  7.94     
C (HMO) 9.91  7.68     
D (HMO) 9.69 7.11
E (HMO) 10.48 7.47   
Prescriptions Filled During Past 30 Days (N)
0 9.17 .1283‡ 6.91 .2597‡
1–2   9.98  7.29
3–4   10.20  7.90
≥ 5   10.51  7.69
*16-Item true–false questionnaire.
†14-Item multiple-choice questionnaire.
‡One-way analysis of variance. 
§Independent samples t test.
¶Excellent > poor (P = .007) after Bonferroni adjustment.
Excellent, good, fair > poor (P = .0001, P = .0001, P = .031; respectively) after 
Bonferroni adjustment.
**Excellent, Good > Fair (P = .003, P = .009; respectively) after Bonferroni adjustment.
These knowledge deficits may lead to misconceptions
about formulary management. In fact, comments on
the questionnaires suggest that respondents perceive
formulary decisions as strictly being made on cost
with little regard for value, quality, or positive health
care outcomes. These misconceptions may precipitate
unnecessary questions to health care providers and ul-
timately lead to consumer dissatisfaction. If formu-
lary management is to remain a fundamental tool for
pharmacy benefits managers, a full and transparent
disclosure of the process is necessary to ease the con-
cerns of consumers and encourage their active par-
ticipation to facilitate medication management with-
in the context of their pharmacy benefits.
Although most respondents were able to recognize
that their fixed out-of-pocket cost for each prescrip-
tion is known as a copay and that their employer and
health insurer determine their out-of-pocket cost col-
lectively, only a small minority of respondents was
able to discern among a copay, coinsurance, or de-
ductible. This lack of knowledge is cause for concern,
as plan sponsors turn to complex strategies to increase
member cost sharing such as deductibles, tiered coin-
surances, and reference pricing14,19 with little knowl-
edge of how well consumers understand these con-
cepts. Recent research concluded that adding
copayment levels, increasing copayments or coin-
surance, or requiring mandatory generic substitution
reduced health insurer drug spending but placed
greater out-of-pocket cost burden on the beneficiary,21
which raises the question of whether lack of knowl-
edge of pharmacy benefits contributes to this in-
creased cost sharing.
Respondents did not appear to understand that
their employer pays for the majority of their pharmacy
benefits. Interestingly, large minorities of respondents
believed that either the health insurer or the employee
paid the largest portion of their pharmacy benefits.
These misperceptions regarding who primarily funds
the pharmacy benefits may lead to distorted consumer
expectations and demand. 
Limitations. This pilot study represents an initial at-
tempt to objectively examine the pharmacy benefit
knowledge of employees in a large employer group
at one point in time, March 2002. Although benefit
structures are revised periodically, the concepts test-
ed in this research remain fundamental to strategies
used to manage pharmacy benefits today. Further-
more, this study tests comprehension of the infor-
mation presented to employees about their benefits.
Thus, the results should raise concerns about the re-
tention of benefit information, and should stimulate
the development, implementation, and testing of al-
ternative benefits education strategies to improve em-
ployee comprehension and retention.
The two main questions that arise are related to
sampling and questionnaire validity, and should be
refined in future work. The sample is relatively ho-
mogenous with respect to race and education, two
characteristics expected to have a strong relationship
with knowledge. Furthermore, this research de-
scribes a working-age sample and does not include
the nonworking and senior populations. The sample
also excludes individuals who waive their health ben-
efits. The restricted diversity of the sample reduced
the generalizability of the results and most likely con-
tributed to the limited explanatory power of the mul-
tivariate regression models. 
Given the diversity of pharmacy benefit offerings
across the general population, this sample was cho-
sen for study to objectively verify the responses to the
knowledge test within a defined population with a
specific set of benefit offerings. The response rate was
lower than desired, and the data did not exist to com-
pare the observed sample demographic characteris-
tics with those of the target population. With the ex-
ception of the disproportionately high percentage of
female respondents, however, the respondent sample
is generally what one would expect in this university-
based employer. 
The ability to enhance response with additional 
follow-up of nonrespondents was limited by a guar-
antee of anonymity. Future research should include
additional methods to improve follow-up of nonre-
spondents.
As expected with survey research, it is assumed that
study participants responded truthfully and accu-
rately. However, it is not certain whether the questions
captured all there is to know about pharmacy bene-
fits. The results from this study are derived from one
large employer sample and thus extrapolation of re-
sults must be performed with caution.
Splitting the sample and administering two differ-
ent questionnaires allowed for expanding the test item
pool and an exploration of different testing formats for
assessing pharmacy benefits knowledge. Although
there was an insufficient sample to test the level of item
difficulty, similar questions appear to elicit similar re-
sponses. In this study, questionnaire items were de-
rived from educational materials distributed to all em-
ployees with a common benefit. Therefore, a correct
answer for each individual questionnaire item could
be assigned. For example, questions may arise as to
whether the employer had input into a preferred drug
list. Although some employers rely solely on the pro-
posed preferred drug list developed by a contracted
pharmacy benefits manager without providing input,
the self-insured employer group in this study adds and
deletes covered products proposed by the contracted
pharmacy benefit manager and approves the final pre-
ferred drug list. Therefore, the employer group under
study has input into the development of the preferred
drug list. Another difference in interpretation may arise
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with respect to the interpretation of the terms copay,
coinsurance, and deductible. The employer group un-
der study used the Academy of Managed Care Phar-
macy, Alexandria,  Virginia, distinction with respect
to cost sharing that a copayment is a flat dollar amount
wheras a co-insurance is a defined percentage of the
charges for services rendered.20
C O N C L U S I O N
Two questionnaires to assess employee knowledge of
pharmacy benefits were used in a large employee pop-
ulation. Both versions demonstrated sufficient content
and construct validity with similar internal consis-
tency suitable for decision making at the group level.
Alternative testing formats (true–false vs. multiple-
choice) derived from identical material, however, may
reveal different levels of aggregate knowledge in
seemingly comparable samples. Although a majority
of the respondent sample could accurately discern ba-
sic concepts (e.g., generic vs. brand medications) and
recognize common terminology (e.g., copay), overall
knowledge about pharmacy benefits was low to mod-
erate and appears to be inadequate for empowered de-
cision making in a market-based system. Specifical-
ly, knowledge of pharmacy benefits was most limited
with respect to formulary management, cost-
sharing and financial implications of out-of-network
use and generic/brand selection. Future research
should strive to refine these newly developed in-
struments into one ideal format and replicate the
study in more diverse samples. Once the prevalence
and characteristics associated with inadequate phar-
macy benefit knowledge are established, methods can
be developed and targeted to improve consumer un-
derstanding. In addition, the relationships between
pharmacy benefit knowledge and health care out-
comes, such as satisfaction, utilization, and cost,
should be explored.
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